BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 125273
Published online Nov 15, 2026. doi: 10.4251/wjgo.125273
Table 4 Biologic strategies for inflammatory bowel disease
Biologic effect
Treatment
Dose scheme
Mechanism
Response
Ref.
TNF-α inhibitorInfliximabInduction: Intravenously 5 mg/kg, 2 weeks and 6 weeksMonoclonal antibody against TNF-αClinical remission, reduced fistulous disease in UC[91,180,181]
Maintenance: Every 8 weeks thereafter
AdalimumabInduction: 160 mg followed by 80 mg after two weeksFully humanized IgG1 monoclonal antibody against TNF-αInduction and maintenance of remission in CD[91,182,183]
Maintenance: 40 mg every two weeksSome patients do not respond
UstekinumabInduction: 130 mg fixed dose or 6 mg/kg for 8-12 weeksIgG1 monoclonal antibody that binds to p40 subunit of pro-inflammatory IL 12 and 23Clinical remission in UC[90,91,180,184]
Maintenance: 90 mg every 8-12 weeks
RisankizumabInduction: 600 mg for12 weeks, or 1200 mg at 0 weeks, 4 weeks, and 8 weeksAntibody binds to p19 subunit of IL-23Improved clinical remission rate with short-term efficacy and safety in moderate-to-severe UC[91,185]
Maintenance: 180 mg or 360 mg every 8 weeks
Anti-adhesion molecule inhibitorsVedolizumabInduction: 300 mg at initial, 2 weeks and 6 weeksMonoclonal IgG1 antibody against α4-β7 integrin, and disruption of lymphocyte traffickingClinical and safety outcomes at 6-10 weeks in moderately to severe CD[91,186]
Maintenance: Same dose every 8 weeks
JAK inhibitorsUpadacitinibInduction: 45 mg/day for 12 weeksImmunosuppression by targeting JAK1Clinical remission and endoscopic response in CD[91,187,188]
Maintenance: 15-30 mg/day for 52 weeksImprovement of fecal calprotectin and C-reactive protein levels
TofacitinibInduction: 10 mg twice a day for 8 weeksInhibition of JAK1 and JAK3, JAK2 and TYK2, blocking signaling for IL-2, IL-4, IL-6, IL-7, IL-9, IL-15, IL-21, and IFN-γ cytokinesClinical response improvement and reduce of inflammatory markers in UC[90,91,189-191]
Maintenance: 5-10 mg twice a day for 26 weeks


Write to the Help Desk